PPAR-γ agonists, insulin resistance and dyslipidemia: not a simple relationship-Reference-Cited by-同舟云学术

PPAR-γ agonists, insulin resistance and dyslipidemia: not a simple relationship

Published:2010-08-01 Issue:4 Volume:5 Page:509-525
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Johns Barry R¹,Reaven Gerald M¹

Affiliation:

1. Stanford University School of Medicine, 300 Pasteur Drive Falk CVRC, MC 5406 Stanford, CA 94305, USA

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.10.36

Reference90 articles.

1. Kawamatsu Y, Saraie T, Imamiya E, Nishikawa K, Hamuro Y: Studies on antihyperlipidemic agents. 1. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives. Arzein-Forsch 30(3), 454–459 (1980).

2. Sohda T, Mizuno K, Tawada H, Sigiyama Y, Fujita T, Kawamatsu Y: Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl] thiazolidenedione -2, 4-dione (AL-321) and related compounds. Chem. Pharm. Bull. 30(10), 3563–3573 (1982).

3. Lazar MA: Mechanism of action of hormones that act on nuclear receptors. In: Williams Textbook of Endocrinology (11th edition). Kronenberg HM (Ed.). Saunders Elsevier, PA, USA, 38–39 (2008).

4. Ruan X, Zheng F, Guan Y: PPARs and the kidney in metabolic syndrome. Am. J. Physiol. Renal Physiol. 294(5), F1032–F1047 (2008).

5. Yki-Jarvinen H: Drug therapy: thiazolidinediones. N. Engl. J. Med. 351(11), 1106–1118 (2004).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogenic and Antioxidant Activities of Pterocarpus soyauxii (Fabaceae) Heartwood Aqueous Extract in Bilateral Oophorectomized Wistar Rat;Evidence-Based Complementary and Alternative Medicine;2021-09-30

2. iNOS as a metabolic enzyme under stress conditions;Free Radical Biology and Medicine;2020-01

3. Design, Synthesis, and Structure-Activity Relationships of Bavachinin Analogues as Peroxisome Proliferator-Activated Receptor γ Agonists;ChemMedChem;2016-12-13

4. Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling;European Journal of Medicinal Chemistry;2011-06